Table 1. Clinically Identified Risk Factors of Bare Metal Stent and Drug-Eluting Stent Thrombosis Bare metal stent thrombosis Drug-eluting stent thrombosis Ref. Table 1. Clinically Identified Risk ...

CureGene Pharmaceutical ('CureGene'), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular and antiviral disease, proudly announces the ...

Platelets play an important role in atherothrombotic disease. The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated ...

A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ...

Grapefruit is a common citrus fruit known for interacting with numerous medications. This may affect how well these medicines ...

Additional drugs significantly associated with increased BP risk included gliptins (OR, 2.77; 95% CI, 2.37-3.23) and second-generation antipsychotics (OR, 2.58; 95% CI, 2.20-3.03). Antiplatelet drugs ...

A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered ...

A study reveals significant inequities in access to heart medications across Canada, highlighting regional disparities in ...

Moyamoya disease (Moyamoya disease) is a disease in which the terminal part of arterial blood vessels in the brain that ...

Advances in cardiovascular pharmacology have significantly enhanced patient outcomes through a new wave of medications ranging from anticoagulants and antiplatelet agents to lipid-lowering drugs and ...

Peripheral Artery Disease (PAD) is characterized by narrowed peripheral arteries, often due to atherosclerosis. Symptoms ...

A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular ...